The Journal of Heart and Lung Transplantation
Volume 29, Issue 9 , Pages 1034-1038 , September 2010

Pandemic influenza (H1N1): Impact on lung transplant recipients and candidates

  • Benjamin Daniel Fox, MB, BS

      Affiliations

    • Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Yael Raviv, MD

      Affiliations

    • Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    • ,
  • Dror Rozengarten, MD

      Affiliations

    • Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    • ,
  • Viktoria Rusanov, MD

      Affiliations

    • Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    • ,
  • Ilana Bakal, RN

      Affiliations

    • Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    • ,
  • Mordechai R. Kramer, MD

      Affiliations

    • Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Corresponding Author InformationReprint requests: Mordechai R. Kramer, MD, Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49100, Israel. Telephone: 972-3-937-7221. Fax: 972-3-924-2091

References 

  1. Chan M. World now at the start of 2009 influenza pandemic (WHO 2009). http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.htmlAccessed: Jan 15, 2010
  2. Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med. 2010;38(4 suppl):e52–e57
  3. Danziger-Isakov LA, Husain S, Mooney ML, Hannan MM. The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant. 2009;28:1341–1347
  4. Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant. 2010;10:18–25
  5. Mendelson E, Mandelboim M, Grossman Z, Ram D, Hindiyeh M. Laboratory diagnosis of influenza H1N1 2009 at the Central Virology Laboratory in Israel during the first 12 weeks of the pandemic. Harefuah. 2009;148:677–681735
  6. Ministry of Health Israel weekly update on H1N1 influenza. http://www.health.org.il/Download/papers/flu020110.pdfAccessed Mar 25, 2009
  7. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181:72–79
  8. Kumar D, Husain S, Chen MH, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation. 2010;27(89):1028–1033
  9. Dopp JM, Wiegert NA, Moran JJ, et al. Effect of annual influenza immunization on antibody response in lung transplant patients. Prog Transplant. 2009;19:153–159
  10. Hayney MS, Moran J, Wiegert NA, Burlingham WJ. Lung transplant patients' T cell responses to influenza vaccine viruses between seasons. Vaccine. 2008;26:2596–2600
  11. Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC. Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant. 2008;27:282–288
  12. Ling LM, Chow AL, Lye DC, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis. 2010;50:963–969

PII: S1053-2498(10)00288-3

doi: 10.1016/j.healun.2010.05.007

The Journal of Heart and Lung Transplantation
Volume 29, Issue 9 , Pages 1034-1038 , September 2010

Article Tools

* Image Usage & Resolution